The store will not work correctly when cookies are disabled.
2-(2,6-dichlorophenyl)-6-methoxy-4-(phenylselanyl)quinoline
ID: ALA4647121
PubChem CID: 156021839
Max Phase: Preclinical
Molecular Formula: C22H15Cl2NOSe
Molecular Weight: 459.23
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc2nc(-c3c(Cl)cccc3Cl)cc([Se]c3ccccc3)c2c1
Standard InChI: InChI=1S/C22H15Cl2NOSe/c1-26-14-10-11-19-16(12-14)21(27-15-6-3-2-4-7-15)13-20(25-19)22-17(23)8-5-9-18(22)24/h2-13H,1H3
Standard InChI Key: WAHXCTZWNKMVJK-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
16.6396 -23.5623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6384 -24.3818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3465 -24.7908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3447 -23.1534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0533 -23.5587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0541 -24.3777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7626 -24.7848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4709 -24.3740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4661 -23.5518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7570 -23.1485 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.7643 -25.6020 0.0000 Se 0 0 0 0 0 2 0 0 0 0 0 0
19.4728 -26.0091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4712 -26.8239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1789 -27.2310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8868 -26.8209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8824 -25.9995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1741 -25.5961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1713 -23.1389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9304 -24.7899 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.2230 -24.3807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8788 -23.5467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5836 -23.1345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5790 -22.3164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8639 -21.9123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1621 -22.3269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8815 -24.3639 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
19.4500 -21.9258 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
7 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
9 18 1 0
2 19 1 0
19 20 1 0
18 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 18 1 0
21 26 1 0
25 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 459.23 | Molecular Weight (Monoisotopic): 458.9696 | AlogP: ┄ | #Rotatable Bonds: ┄ |
Polar Surface Area: ┄ | Molecular Species: ┄ | HBA: ┄ | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): ┄ | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: ┄ | CX LogD: ┄ |
Aromatic Rings: ┄ | Heavy Atoms: ┄ | QED Weighted: ┄ | Np Likeness Score: ┄ |
References
1. Costa CA, Lopes RM, Ferraz LS, Esteves GNN, Di Iorio JF, Souza AA, de Oliveira IM, Manarin F, Judice WAS, Stefani HA, Rodrigues T.. (2020) Cytotoxicity of 4-substituted quinoline derivatives: Anticancer and antileishmanial potential., 28 (11): [PMID:32336669] [10.1016/j.bmc.2020.115511] |